Related Experiment Video
Updated: Jun 30, 2025

A Novel in vivo Gene Transfer Technique and in vitro Cell Based Assays for the Study of Bone Loss in Musculoskeletal Disorders
Published on: June 8, 2014
Immunomodulatory nanomedicine for osteoporosis: Current practices and emerging prospects
Yankun Luo1, Hanghang Liu1, Ming Chen2
1State Key Laboratory of Oral Diseases & National Center for Stomatology& National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu 610041, Sichuan, China.
Abstract:
Osteoporosis results from the disruption of the balance between bone resorption and bone formation. However, classical anti-osteoporosis drugs exhibit several limitations in clinical applications, such as multiple adverse reactions and poor therapeutic effects. Therefore, there is an urgent need for alternative treatment strategies. With the evolution of immunomodulatory nanomedicine, a variety of nanomaterials have been designed for anti-osteoporosis treatment, offering prospects of minimal adverse reactions, enhanced bone induction, and high osteogenic activity. This review initially provides a brief overview of the fundamental principles of bone reconstruction, current osteogenic clinical methods in osteoporosis treatment, and the significance of osteogenic-angiogenic coupling, laying the groundwork for understanding the pathophysiology and therapeutics of osteoporosis. Subsequently, the article emphasizes the relationship between bone immunity and osteogenesis-angiogenesis coupling and provides a detailed analysis of the application of immunomodulatory nanomedicines in the treatment of osteoporosis, including various types of nanomaterials and their integration with carrier biomaterials. Importantly, we discuss the potential of some emerging strategies in immunomodulatory nanomedicine for osteoporosis treatment. This review introduces the innovative applications of immunomodulatory nanomedicine in the treatment of osteoporosis, aiming to serve as a reference for the application of immunomodulatory nanomedicine strategies in osteoporosis treatment. STATEMENT OF SIGNIFICANCE: Osteoporosis, as one of the most prevalent skeletal disorders, poses a significant threat to public health. To date, conventional anti-osteoporosis strategies have been limited in efficacy and plagued with numerous side effects. Fortunately, with the advancement of research in osteoimmunology and nanomedicine, strategies integrating these two fields show great promise in combating osteoporosis. Nanomedicine with immunomodulatory properties exhibits enhanced efficiency, prolonged effectiveness, and increased safety. However, as of now, there exists no comprehensive review amalgamating immunomodulation with nanomedicine to delineate the progress of immunomodulatory nanomedicine in osteoporosis treatment, as well as the future direction of this strategy.
Insights
Immunomodulatory nanomedicine offers a promising alternative for osteoporosis treatment, overcoming limitations of traditional drugs. This approach enhances bone formation and reduces adverse effects for improved osteoporosis therapy.
Area of Science:
- Osteoimmunology and Nanomedicine
- Biomaterials Science
- Skeletal Biology
Background:
- Osteoporosis disrupts bone remodeling, necessitating novel treatments beyond conventional drugs with adverse effects.
- Current therapies for osteoporosis face limitations in efficacy and safety, driving the search for advanced strategies.
- Understanding osteoimmunology and osteogenic-angiogenic coupling is crucial for developing effective osteoporosis treatments.
Purpose of the Study:
- To review the application of immunomodulatory nanomedicine in treating osteoporosis.
- To analyze the integration of nanomaterials with carrier biomaterials for enhanced osteoporosis therapy.
- To discuss emerging strategies and future directions in nanomedicine for osteoporosis.
Main Methods:
- Literature review of immunomodulatory nanomedicine applications in osteoporosis.
- Analysis of nanomaterial types and their integration with biomaterials.
- Exploration of osteoimmunology and osteogenesis-angiogenesis coupling principles.
Main Results:
- Immunomodulatory nanomedicines show potential for minimal adverse reactions and enhanced bone induction in osteoporosis.
- Nanomaterials offer improved osteogenic activity and therapeutic effects compared to traditional osteoporosis treatments.
- The integration of nanomedicine and immunomodulation presents a promising avenue for osteoporosis management.
Conclusions:
- Immunomodulatory nanomedicine represents a significant advancement in osteoporosis treatment, offering improved efficacy and safety.
- Further research into emerging strategies within immunomodulatory nanomedicine is warranted for osteoporosis therapy.
- This review provides a comprehensive overview of nanomedicine's role in combating osteoporosis, guiding future research and clinical applications.
More Related Videos
07:12Semiautomated Longitudinal Microcomputed Tomography-based Quantitative Structural Analysis of a Nude Rat Osteoporosis-related Vertebral Fracture Model
Published on: September 28, 2017
07:20Author Spotlight: Integrating Traditional Chinese Medicine with Modern Pharmacology and Genomics for Assessing Postmenopausal Osteoporosis in Mice
Published on: August 23, 2024
Related Concept Videos
Osteoclasts in Bone Remodeling
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Mesenchymal Stem Cells